SCHEMBL5723151

SCHEMBL5723151

CCOC(=O)Cc1coc2c(OC)ccc(C=O)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
ERN1 O75460 2/20 0.37
DPP4 P27487 2/20 0.37
MAPT P10636 5/20 0.36
HPGD P15428 3/20 0.36
PKM P14618 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
EGFR P00533 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839353 0.85 ALDH1A1 (0.43) ALDH1A1ERN1MAPTL3MBTL1GAA
SCHEMBL6833221 0.85 HSD17B10 (0.43) ALDH1A1ERN1MAPTHPGDSMN1; SMN2
SCHEMBL5723142 0.82 DPP4 (0.37) ALDH1A1DPP4MAPTHPGDPKM
SCHEMBL6839194 0.75 PSMB5 (0.49) ALDH1A1CYP1A2DPP4MAPTHPGD
SCHEMBL5724152 0.75 PDE4B (0.36) ALDH1A1DPP4MAPTLMNASMN1; SMN2
SCHEMBL6837979 0.74 PDE4D (0.41) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL23115224 0.73 TSHR (0.43) ALDH1A1DPP4MAPTHPGDKDM4E
SCHEMBL73915 0.73 RAB9A (0.47) ERN1MAPTSMN1; SMN2RAB9AKDM4E
SCHEMBL23116692 0.73 MAPT (0.40) ALDH1A1DPP4MAPTHPGDLMNA
SCHEMBL5723032 0.73 PDE4D (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771794-B1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KK (JP) 2006-05-03 EP disclosed
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed
EP-0771794-A1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 ALDH1A1 323/4885CYP1A2 103/4885CYP2C19 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.